Procedures for monograph and list entry establishment
Procedures for monograph and list entry establishment
Procedures for monograph and list entry establishment
Expected publication dates of PRAC recommendations on safety signals
Human medicines European public assessment report (EPAR): Truxima, rituximab, Date of authorisation: 17/02/2017, Revision: 21, Status: Authorised
Human medicines European public assessment report (EPAR): Blitzima, rituximab, Date of authorisation: 13/07/2017, Revision: 20, Status: Authorised
Summary of opinion: Frontpro (previously known as Afoxolaner Merial), 07/12/2023 Positive
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 5-7 December 2023
Global regulators strengthen efforts to ensure continuous availability of safe and high-quality medicines
EU Implementation Guide (IG) on veterinary medicines product data - Chapter 2: Format for the electronic submission of veterinary medicinal product information
Human medicines European public assessment report (EPAR): Ivozall, clofarabine, Date of authorisation: 14/11/2019, Revision: 5, Status: Withdrawn
Human medicines European public assessment report (EPAR): Vidaza, azacitidine, Date of authorisation: 17/12/2008, Revision: 27, Status: Authorised